ARCHIVES

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Surprise Finding On HRT Stops Large Trial, Women Advised To Reconsider Long-Term Use Due to Increased Breast Cancer Risk

July 12, 2002

NIH-funded HapMap consortium publishes first phase of catalog.

October 28, 2005

Nobel Prize Recognizes Gene Targeting.

October 12, 2007

Includes Sept. Business & Regulatory Report.

September 26, 2003

Foon Moves To UPCI

April 18, 2003

NCI to hold 5 percent of division budgets in reserve for “strategic priorities.” Competing RPG budgets to be cut 18 percent on average.

February 13, 2004